We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Search results

From Proteopedia

You searched for Repurposing

Jump to: navigation, search

There is no page with the exact title "Repurposing". The search results for "Repurposing" are displayed below. You can create a page titled Repurposing (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Drug repurposing (47 bytes)
    1: List of pages with the keyword Drug repurposing
  2. Category:Repurposing (42 bytes)
    1: List of pages with the keyword Repurposing

Page text matches

  1. 8w4q (5,023 bytes)
    16: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
    18: Drug repurposing and structure-based discovery of new PDE4 and PDE...
  2. 8w4r (5,049 bytes)
    16: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
    18: Drug repurposing and structure-based discovery of new PDE4 and PDE...
  3. 8w4s (4,130 bytes)
    14: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
    16: Drug repurposing and structure-based discovery of new PDE4 and PDE...
  4. 8w4t (4,138 bytes)
    14: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
    16: Drug repurposing and structure-based discovery of new PDE4 and PDE...
  5. 4ij1 (4,212 bytes)
    16: Repurposing the chemical scaffold of the anti-arthritic drug ...
  6. 4cyr (4,544 bytes)
    14: ...an altering the catalytic machinery, evolutionary repurposing was achieved by fine-tuning the molecular recogni...
    16: Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to ...
  7. 4cys (4,647 bytes)
    14: ...an altering the catalytic machinery, evolutionary repurposing was achieved by fine-tuning the molecular recogni...
    16: Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to ...
  8. 8zas (3,386 bytes)
    14: From Theophylline to Adenine or preQ(1): Repurposing a DNA Aptamer Revealed by Crystal Structure Analy...
  9. 2xuc (4,276 bytes)
    14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product.
  10. 2xvp (3,629 bytes)
    14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product.
  11. 2xvn (4,215 bytes)
    14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product.
  12. 8h2t (4,015 bytes)
    14: ...erichia coli, suggesting a promising strategy for repurposing the iad operon for IAA regulation. Together, our ...
  13. 9gu8 (4,198 bytes)
    16: FDA Drug Repurposing Uncovers Modulators of Dopamine D(2) Receptor Loc...
  14. 9gu6 (4,295 bytes)
    16: FDA Drug Repurposing Uncovers Modulators of Dopamine D(2) Receptor Loc...
  15. 9gto (4,181 bytes)
    16: FDA Drug Repurposing Uncovers Modulators of Dopamine D(2) Receptor Loc...
  16. 8ev1 (7,450 bytes)
    14: ...ned ligand-based and structure-based multi-target repurposing strategy and applied it to a series of hexahydroc...
  17. 8ev2 (7,422 bytes)
    14: ...ned ligand-based and structure-based multi-target repurposing strategy and applied it to a series of hexahydroc...
  18. 8bdy (5,053 bytes)
    16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
    18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ...
  19. 8bd9 (5,053 bytes)
    16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
    18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ...
  20. 8bd8 (5,052 bytes)
    16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
    18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools